Association between alopecia areata and cardiovascular disease: a systematic review and meta-analysis

Jiawei Lu1, Xuechen Cao1, Yifei Feng1

  • 1Department of Dermatology, The First Affiliated Hospital with Nanjing Medical University, Nanjing, China.

Frontiers in Immunology
|August 25, 2025
PubMed

Insights

Alopecia areata (AA) patients, particularly those with severe forms like alopecia totalis or universalis, face a higher risk of cardiovascular disease (CVD). This link may stem from shared inflammatory pathways, warranting further investigation into cardiovascular health in AA patients.

Area of Science:

  • Cardiovascular Epidemiology
  • Dermatology
  • Autoimmune Disorders

Background:

  • Alopecia areata (AA) is a common autoimmune condition causing patchy hair loss.
  • Emerging evidence suggests a potential link between AA and cardiovascular disease (CVD), though this relationship requires further clarification.

Purpose of the Study:

  • To conduct a meta-analysis to quantitatively assess the association between alopecia areata and cardiovascular disease.
  • To investigate potential differences in CVD risk based on AA subtypes.

Main Methods:

  • Systematic literature search of four major databases (MEDLINE, Embase, Web of Science, Cochrane Library) up to December 2024.
  • Inclusion of cohort and case-control studies evaluating the AA-CVD relationship.
  • Meta-analysis using a random-effects model to calculate odds ratios (OR) and 95% confidence intervals (CIs).

Main Results:

  • Five studies comprising 238,270 patients revealed a significantly increased odds of CVD in AA patients (OR = 1.71; 95% CI: 1.0 to 2.92).
  • Patients with alopecia totalis or alopecia universalis showed a markedly higher risk (OR = 3.80; 95% CI: 1.65 to 8.73).
  • No significant association was found between patch-type AA and CVD, nor specifically with ischemic stroke or myocardial infarction.

Conclusions:

  • Alopecia areata, especially severe forms, is associated with an elevated risk of cardiovascular disease.
  • Systemic inflammation in AA may contribute to atherosclerosis and increased cardiovascular risk.
  • Further research is essential to confirm these findings and elucidate the underlying pathophysiological mechanisms.
Abstract

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
78
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
55
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
4.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
34
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
47